Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
6.06
+1.05 (20.96%)
At close: Oct 31, 2025, 4:00 PM EDT
6.01
-0.05 (-0.83%)
After-hours: Oct 31, 2025, 7:59 PM EDT
Ardelyx Revenue
Ardelyx had revenue of $110.33M in the quarter ending September 30, 2025, with 12.30% growth. This brings the company's revenue in the last twelve months to $398.23M, up 58.12% year-over-year. In the year 2024, Ardelyx had annual revenue of $333.62M with 168.06% growth.
Revenue (ttm)
$398.23M
Revenue Growth
+58.12%
P/S Ratio
3.64
Revenue / Employee
$1,008,187
Employees
395
Market Cap
1.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.62M | 209.16M | 168.06% |
| Dec 31, 2023 | 124.46M | 72.30M | 138.61% |
| Dec 31, 2022 | 52.16M | 42.06M | 416.57% |
| Dec 31, 2021 | 10.10M | 2.53M | 33.36% |
| Dec 31, 2020 | 7.57M | 2.29M | 43.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
ARDX News
- 2 days ago - Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting - GlobeNewsWire
- 12 days ago - Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week - GlobeNewsWire
- 20 days ago - Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025 - GlobeNewsWire
- 20 days ago - Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha